A comparison of α-methylnorepinephrine, vasopressin and epinephrine for cardiac resuscitation

Resuscitation

Volumn 57, Issue 1, 2003, Pages 93-100

  Klouche, Kada ^a   Weil, Max Harry ^a,b   Sun, Shijie ^a,b   Tang, Wanchun ^a,b   Zhao, Dan Hong ^a  

^a INSTITUTE OF CRITICAL CARE MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cardiopulmonary resuscitation (CPR); Epinephrine; Post resuscitation myocardial dysfunction; Vasopressin; Ventricular fibrillation; 2 Adrenergic agonist

Indexed keywords

ADRENALIN; CORBADRINE; VASOPRESSIN;

ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; COMPRESSION THERAPY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DEFIBRILLATION; DRUG EFFECT; DRUG MECHANISM; HEART FUNCTION; HEART INDEX; HEART LEFT VENTRICLE PRESSURE; HEART VENTRICLE FIBRILLATION; MALE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; RESUSCITATION; SURVIVAL;

EID: 0037379917     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(02)00403-3     Document Type: Article

References (47)

1. Ditchey R.V., Lindenfeld J. Failure of epinephrine to improve the balance between myocardial oxygen supply and demand during closed-chest resuscitation in dogs. Circulation. 78:1988;382-389.
2. Tang W., Weil M.H., Sun S.J., Noc M., Yang L., Gazmuri R.J. Epinephrine increases the severity of post-resuscitation myocardial dysfunction. Circulation. 92:1995;3089-3093.
3. Lefkowitz RJ. Neurotransmission: the autonomic and somatic motor nervous system. In: Goodman & Gilman's. The pharmacological basis of therapeutics, 9th ed., New York, NY: McGraw-Hill, 1996:125.
4. Broadley K.J., Williamson K.L., Roach A.G. In vivo demonstration of alpha-adrenoceptor-mediated positive inotropy in pithed rats: evidence that noradrenaline does not stimulate myocardial alpha-adrenoceptors. J. Auton. Pharmacol. 19:(1):1999;55-63.
5. Lindner K.H., Brinkmann A., Pfenninger E.G., Lurie K.G., Goertz A., Lindner I.M. Effect of vasopressin on hemodynamic variables, organ blood flow and acid base status in a pig model of cardiopulmonary resuscitation. Anesth. Analg. 7:1993;427-435.
6. Lindner K.H., Prengel A.W., Pfenninger E.G., et al. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation. 91:1995;215-221.
7. The American Heart Association in collaboration with the International Liaison Committee on Resuscitation. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care, Circulation 2000; 8 (Suppl): I-129-35.
8. Gudipati C.V., Weil M.H., Bisera J., Deshmukh H.G., Rackow E.C. Expired carbon dioxide: a non-invasive monitor of cardiopulmonary resuscitation. Circulation. 77:1988;234-239.
9. 2-adrenergic agonist for cardiac resuscitation. J. Am. Coll. Cardiol. 37:2001;951-956.
10. Nieman J.T., Haynes K.S., Garner D., Renie C.J., Jagels G., Storm O. Post-countershock pulseless rhythms: response to CPR, artificial cardiac pacing, and adrenergic agonists. Ann. Emerg. Med. 15:1986;112-120.
11. Brown C.G., Birinyi F., Werman H.A., Davis E.A., Hamlin R.L. The comparative effects of epinephrine versus phenylephrine on regional cerebral blood flow during cardiopulmonary resuscitation. Resuscitation. 14:1986;171-183.
12. Dillon J.S., Gu X.H., Nayler W.G. Alpha 1 adrenoceptors in the ischemic and reperfused myocardium. J. Mol. Cell. Cardiol. 20:1988;725-735.
13. Zhao M., Hagler H.K., Muntz K.H. Regulation of alpha 1-, beta 1-, and beta 2-adrenergic receptors in rat heart by norepinephrine. Am. J. Physiol. 271:1996;H1762-H1768.
14. 1 β-adrenergic receptor induces left ventricular dysfunction in the absence of hypertrophy. Am. J. Physiol. 275:1998;H1338-H1350.
15. Weil M.H., Bisera J., Trevino R.P., Rackow E.C. Cardiac output and end-tidal carbon-dioxide. Crit. Care Med. 13:1985;907-909.
16. Tang W., Weil M.H., Gazmuri R.J., Sun S., Duggal C., Bisera J. Pulmonary ventilation/perfusion defects induced by epinephrine during cardiopulmonary resuscitation. Circulation. 84:1991;2101-2107.
17. Evora P.R.B., Pearson P.J., Schaff H.V. Arginine vasopressin induces endothelium-dependent vasodilatation on the pulmonary artery. V1-receptor-mediated production of nitric oxide. Chest. 103:1993;1241-1245.
18. Meissner A., Weber T.P., Van Aken H., Zbieranek K., Rolf N. Clonidine improves recovery from myocardial stunning in conscious chronically instrumented dogs. Anesth. Analg. 87:1998;1009-1014.
19. Stuhmeier K.D., Mainzer B., Cierpka J., Sandmann W., Tarnow J. Small, oral dose of clonidine reduces the incidence of intraoperative myocardial ischemia in patients having vascular surgery. Anesthesiology. 85:1996;706-712.
20. McSPI-Europe Research group. Perioperative sympatholysis. Beneficial effects of the alpha 2-adrenoreceptor agonist mivazerol on hemodynamic stability and myocardial ischemia, Anesthesiology 1997; 86: 346-63.
21. Brodde O.E. Physiology and pharmacology of cardiovascular catecholamine receptors: implications for treatment of chronic heart failure. Am. Heart J. 120:1990;1565-1572.
22. Ishibashi Y., Duncker D.J., Bache R.J. Endogenous nitric oxide masks alpha 2-adrenergic coronary vasoconstriction during exercise in the ischemic heart. Circ. Res. 80:1997;196-207.
23. Lindner K.H., Haak T., Keller A., Bothner U., Lurie K.G. Release of endogenous vasopressors during and after cardiopulmonary resuscitation. Heart. 75:1996;145-150.
24. Kahn Z.P., Ferguson C.N., Jones R.M. Alpha-2 and imadazoline receptor agonists. Their pharmacology and therapeutic role. Anesthesia. 54:1999;146-165.
25. Shinnou M., Ueno M., Sakamoto H., Ide M. Blood-brain barrier damage in reperfusion following ischemia in the hippocampus of the Mongolian gerbil brain. Acta Neurol. Scand. 98:1998;406-411.
26. Schleien C.L., Koehler R.C., Shaffner D.H., Traystman R.J. Blood-brain barrier integrity during cardiopulmonary resuscitation in dogs. Stroke. 21:1990;1185-1191.
27. Schäfers R.F., Nurnberger J., Herrmann B., Wenzel R.R., Philipp T., Michel M.C. Adrenoreceptors mediating the cardiovascular and metabolic effects of α-methylnoradrenaline in humans. J. Pharmacol. Exp. Ther. 289:1999;918-925.
28. Wenzel V., Lindner K.H., Prengel A.W., et al. Vasopressin improves vital organ blood flow after prolonged cardiac arrest with postcountershock pulseless electrical activity in pigs. Crit. Care Med. 27:1999;486-492.
29. Wenzel V., Lindner K.H., Krismer A.C., Miller E.A., Voelckel W.G., Lingnau W. Repeated administration of vasopressin but not epinephrine maintains coronary perfusion pressure after early and late administration during prolonged cardiopulmonary resuscitation in pigs. Circulation. 99:1999;1379-1384.
30. Lindner K.H., Prengel A.W., Brinkmann A., Strohmenger H.U., Lindner I.M., Lurie K.G. Vasopressin administration in refractory cardiac arrest. Ann. Intern. Med. 124:1996;1061-1064.
31. Lindner K.H., Dirks B., Strohmenger H.U., Prengel A.W., Lindner I.M., Lurie K.G. A randomized comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet. 349:1997;535-537.
32. Prengel A.W., Lindner K.H., Keller A. Cerebral oxygenation during cardiopulmonary resuscitation with epinephrine and vasopressin in pigs. Stroke. 27:1996;1241-1248.
33. Drapanas T., Crowe C.P. The effect of pitressin on cardiac output and coronary, hepatic, and intestinal blood flow. Surg. Gynecol. Obstet. 113:1961;484-489.
34. Nakano J. Studies on the cardiovascular effects of synthetic vasopressin. J. Pharmacol. Exp. Ther. 157:1967;19-31.
35. Corliss R.J., McKenna D.H., Sialer S., O'Brien G.S., Rowe G.G. Systemic and coronary hemodynamic effects of vasopressin. Am. J. Med. Sci. 256:1968;293-299.
36. Prengel A.W., Lindner K.H., Keller A., Lurie K.G. Cardiovascular function during the post-resuscitation phase after cardiac arrest in pigs: a comparison of epinephrine versus vasopressin. Crit. Care Med. 24:1996;2014-2019.
37. Heyndrickx G.R., Boettcher D.H., Vatner V. Effects of angiotensin, vasopressin and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am. J. Physiol. 231:1976;1579-1587.
38. Nakano J. Cardiovascular actions of vasopressin. Jpn. Circ. J. 37:1973;363-380.
39. Khayyal M.A., Eng C., Franzen D., Breall J.A., Kirk E.S. Effects of vasopressin on the coronary circulation: reserve and regulation during ischemia. Am. J. Physiol. 248:1985;H516-H522.
40. Walker B.R., Childs M.E., Adams E.M. Direct cardiac effects of vasopressin; role of V1- and V2-vasopressinergic receptors. Am. J. Physiol. 255:1988;H261-H265.
41. Cheng C., Igarashi Y., Klopfenstein H.S., Applegate R.J., Shihab Z., Little W.C. Effect of vasopressin on left ventricular performance. Am. J. Physiol. 264:1993;H53-H60.
42. Foreman B.W., Dai X.Z., Bache R.J. Vasoconstriction of canine coronary collateral vessels with vasopressin limits blood flow to collateral-dependent myocardium during exercise. Circ. Res. 69:1991;657-664.
43. Maturi M.F., Martin S.E., Markle D., et al. Coronary vasoconstriction induced by vasopressin. Production of myocardial ischemia in dogs by constriction of nondiseased small vessels. Circulation. 83:1991;2111-2121.
44. Sellke F.W., Quillen J.E. Altered effects of vasopressin on the coronary circulation after ischemia. J. Thorac. Cardiovasc. Surg. 104:1992;357-363.
45. Wenzel V., Lindner K.H., Mayer H., Lurie K.G., Prengel A.W. Vasopressin combined with nitroglycerin increases endocardial perfusion during cardiopulmonary resuscitation in pigs. Resuscitation. 38:1998;13-17.
46. Wenzel V., Lindner K.H., Krismer A.C., et al. Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs. J. Am. Coll. Cardiol. 35:(2):2000;527-533.
47. Babar S.I., Berg R.A., Hilwig R.W., Kern K.B., Ewy G.A. Vasopressin versus epinephrine during cardiopulmonary resuscitation; a randomized swine outcome study. Resuscitation. 41:1999;185-192.